• Maxillofacial Plastic and Reconstructive Surgery
• /
• v.41
• /
• pp.38.1-38.13
• /
• 2019

The application of botulinum in oral and maxillofacial surgery begins in 1982, where Jan Carruthers started using it for reducing the muscle mass and smoothing the skin, and since then it has been used for cosmetic purposes. In Korea, it is already being used by various specialties including dentistry (oral and maxillofacial surgery, oral medicine), plastic surgery, dermatology, ophthalmology, general surgery, and orthopedic surgery, etc. Each specialty approaches to Botox with its own medical indications. In this article, we will discuss the maxillofacial application of botulinum toxin, which includes theoretical and practical aspects of such as bruxism and square jaw.

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.27-27
• /
• 1998

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1997.06a
• /
• pp.54-54
• /
• 1997

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.43-43
• /
• 1998

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.31 no.4
• /
• pp.342-349
• /
• 2005

Recently, the number of facial contouring surgery such as angle reduction or malarplasty in Oral and maxillofacial surgery is increasing steadly as the demand for maxillofacial esthetic surgery of the patients is growing. Looking around international trend of oral and maxillofacial surgery, nowadays workshop or symposium about facial soft esthetic surgery such as corrective rhinoplasty, blepharoplasty, face lift are held. This means that maxillofacial esthetic surgery is new scope which oral and maxillofacial surgeons should develope. Therefore the authors present cases of blepharoplasty which got hardly used to oral and maxillofaical surgeon with literature review in order to raise the concern about maxillofacial esthetic surgery.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.47 no.5
• /
• pp.341-350
• /
• 2021

Dexamethasone has been used in oral and maxillofacial surgery for postoperative pain, swelling, and trismus following third molar surgeries. It is a potent and powerful drug that can alleviate the aforementioned postoperative sequelae. Dexamethasone is responsible for inhibiting the release of inflammatory mediators in the inflammation process to improve patient quality of life after surgical intervention. There are several available routes of administering dexamethasone. This article will help determine the suggested routes of administration, dosage, parameters, and dexamethasone timing for third molar surgeries.

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.41-41
• /
• 1998

• Maxillofacial Plastic and Reconstructive Surgery
• /
• v.41
• /
• pp.45.1-45.9
• /
• 2019

Botulinum toxin (BTX) has various therapeutic indications: bruxism, square jaw, facial wrinkle, oral ulcer and maxillofacial pain, etc. In this paper, we will discuss the effectiveness of using BTX in dental implant surgery and orthognathic and orthodontic treatment. We summarized the clinical application of botulinum toxin in the maxillofacial field at the finale.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• v.32 no.6
• /
• pp.558-562
• /
• 2010

Sinusitis has been reported as a complication of sinus lift surgery. Obstruction of the sinus outflow tract by mucosal edema and particulate graft material may result in sinusitis. Two main surgical procedures have been proposed for the treatment of associated infectious complications; inferior meatal antrostomy and functional endoscopic sinus surgery through transnasal approach. We performed superior lateral wall antrostomy through introral approach in patient suffering from the sinusitis after sinus floor augmentation and implant installation. This procedure permitted easier access to the maxillary sinus for treat sinusitis caused by sinus lifting.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.43 no.3
• /
• pp.212-212
• /
• 2017